The year 2014 was a transition and execution year for Galapagos.
Onno van de Stolpe, CEO
Letter from the CEO
Galapagos greatly expanded its pipeline in 2014
Read more
Strategy
Galapagos seeks to develop clinical-stage breakthrough therapies.
Read more
